文献速递腹部MR

胆道导管内管状乳头状肿瘤与胆道导管内乳头状黏液性肿瘤的影像病理对比研究

Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm.
PubMed 文献 · Abdom Radiol (NY) · 2017-01-01

回顾性分析5例胆道导管内管状乳头状肿瘤(BT-ITPN)与19例胆道导管内乳头状黏液性肿瘤(BT-IPMN)的MRI特征并对照病理。BT-ITPN均表现为胆管扩张、可见导管内软组织及胆管周围肝实质强化,导管内软组织比例显著高于BT-IPMN(p<0.05);缺乏腔内黏液和MUC5AC免疫组化阴性有助于鉴别。

要点

  • BT-ITPN表现为胆管扩张、导管内软组织及胆管周围肝实质强化,导管内软组织比例显著高于BT-IPMN(p<0.05)。
  • 缺乏腔内黏液和MUC5AC免疫组化阴性是鉴别BT-ITPN与BT-IPMN的影像和病理特征。
  • 当出现导管内实性软组织及胆管周围肝实质强化、尤其病灶上下游胆管直径正常且无黏液时,应怀疑BT-ITPN。

核心结论

  • BT-ITPN虽罕见,但当出现导管内实性软组织及胆管周围肝实质强化、尤其病灶上下游胆管直径正常且无黏液时,应怀疑BT-ITPN;鉴于其侵袭性,识别这些特征可能提示需对部分患者采取更积极的治疗。

研究设计与样本

  • 回顾性研究,纳入5例经病理确诊的BT-ITPN且有诊断性MRI资料的患者,并与19例BT-IPMN患者比较;将关键MRI特征与大体和显微镜下病理进行对照。

关键影像表现/征象

  • 所有BT-ITPN均显示胆管扩张、可见导管内软组织及胆管周围肝实质强化。
  • 1例BT-ITPN患者伴同时性肺转移,另1例显示肿瘤快速生长。
  • BT-ITPN的导管内软组织比例显著多于BT-IPMN(p<0.05)。
  • BT-ITPN缺乏腔内黏液,免疫组化MUC5AC阴性,为与BT-IPMN鉴别的影像和病理特征。

诊断标准与关键数值

  • BT-ITPN的导管内软组织比例显著多于BT-IPMN(p<0.05)。
  • BT-ITPN组60%的病例CA-199水平升高。
  • BT-ITPN组总体合并1年和3年生存率分别为100%和40%,BT-IPMN组分别为100%和58%。

临床应用与阅片要点

  • 阅片时注意导管内实性软组织及胆管周围肝实质强化,尤其病灶上下游胆管直径正常且无黏液时,应怀疑BT-ITPN。
  • 注意缺乏腔内黏液和MUC5AC免疫组化阴性有助于与BT-IPMN鉴别。
  • 作者认为,鉴于肿瘤的侵袭性,识别这些特征可能提示需对部分患者采取更积极的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Biliary tract intraductal tubulopapillary neoplasms (BT-ITPNs) and intraductal papillary mucinous neoplasms (BT-IPMNs) are rare and poorly described. Herein, we examined the magnetic resonance imaging (MRI) features of BT-ITPNs and BT-IPMNs and correlated them with key gross and microscopic pathological findings.

METHODS: We retrospectively identified five patients with definitive pathological findings of BT-ITPN and available diagnostic MRI findings. Key MRI features were correlated to the gross and microscopic pathology and compared to those of BT-IPMNs (19 patients).

RESULTS: All BT-ITPNs showed ductal dilatation and visible intraductal soft tissue with peribiliary liver parenchyma enhancement. One BT-ITPN patient had synchronous lung metastases, and another showed rapid tumor growth rate. The intraductal soft tissue proportion of BT-ITPNs was significantly more than that of BT-IPMNs (p < 0.05). CA-199 level was elevated in 60% of BT-ITPN cases. The overall combined 1-year and 3-year survival rates in the BT-ITPN group was 100% and 40%, and in the BT-IPMN group was 100% and 58%, respectively. A high intraductal soft tissue proportion, a lack of intraluminal mucin, and immunohistochemical absence of MUC5AC are radiological and pathological characteristics that differentiate BT-ITPN from BT-IPMN.

CONCLUSIONS: Although rare, BT-ITPN should be suspected when solid intraductal soft tissue and peribiliary liver parenchyma enhancement are present, particularly if the bile duct upstream and downstream of the lesion have a normal diameter, without mucin. Owing to the aggressive nature of the tumor, recognition of these features may indicate the need for more aggressive treatment in selected patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wu CH, Yeh YC, Tsuei YC, et al. Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm. Abdom Radiol (NY). 2017. PMID: 28470400. doi:10.1007/s00261-017-1167-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。